Cabazitaxel (Jevtana®) for Patients with Metastatic Castration Resistant Prostate Cancer – 1

In an effort to promote higher quality patient care NCODA created the NCODA Positive Quality Intervention (PQI) as a peer-reviewed clinical guidance resource for healthcare providers. By providing Quality Standards and effective practices around a specific aspect of cancer care, PQIs equip the entire multidisciplinary care team with a sophisticated yet concise resource for managing patients receiving oral or IV oncolytics. This PQI in Action is a follow up to the Cabazitaxel ( JEVTANA®) For Patients with Metastatic Castration Resistant Prostate Cancer PQI and explores how the Medically Integrated Teams at Carolina Blood and Cancer Care Associates, P.A. and DuPage Medical Group incorporate PQIs as part of their daily workflow. This article will discuss how utilizing the Cabazitaxel ( JEVTANA®) For Patients with Metastatic Castration Resistant Prostate Cancer PQI elevates patient care.